Press release
Update in Lawsuit that was filed for Investors in Obalon Therapeutics Inc (NASDAQ: OBLN) shares
A lawsuit is pending for certain investors in Obalon Therapeutics Inc (NASDAQ: OBLN) shares and Obalon Therapeutics Inc.
Investors who purchased shares of Obalon Therapeutics Inc (NASDAQ: OBLN) and currently hold any of those Obalon Therapeutics Inc (NASDAQ: OBLN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On February 14, 2018, a lawsuit was filed against Obalon Therapeutics Inc (NASDAQ: OBLN) over alleged securities laws violations. The plaintiff alleged that the Defendants failed to disclose that Obalon Therapeutics Inc recognized revenue in violation of Generally Accepted Accounting principles (“GAAP”), that the Company lacked adequate internal controls over accounting and financial reporting, and that, as a result of the foregoing, Obalon Therapeutics Inc’s financial statements and Defendants’ statements about Obalon’s business, operations, and prospects, were materially false and misleading at all relevant times. Recently the court denied in part a motion by the defendants to dismiss the case and the case is moving forward.
Those who purchased shares of Obalon Therapeutics Inc (NASDAQ: OBLN), have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Update in Lawsuit that was filed for Investors in Obalon Therapeutics Inc (NASDAQ: OBLN) shares here
News-ID: 1842091 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Obalon
Weight-Loss Devices Market Trends and Growth Opportunities in 2024 Obalon Therap …
The Weight-Loss Devices Market encompasses a diverse array of medical devices and technologies designed to aid individuals in achieving weight reduction and managing obesity-related health conditions. This market segment is witnessing steady growth globally, driven by factors such as the rising prevalence of obesity and associated health complications, increasing awareness about the importance of weight management, and advancements in medical technology.
Get a free sample copy of the report:-https://www.datamintelligence.com/download-sample/weight-loss-devices-market
Market Trends :
Technological…
Gastric Balloon Market Growing at a CAGR of 9.7% - Leading companies like ENDALI …
Gastric balloons are being preferred for weight loss during recent days. Unlike other procedures for weight loss, the gastric balloons are non-invasive methods for managing weight loss. The gastric balloon is placed through the mouth and is pushed down the esophagus, while it is in its least dilated form. Once the balloon reaches the stomach, it is filled with the saline or gas with the help of a tube, which…
New Comprehensive Report on Obesity Intervention Devices Market 2020-2027| Enter …
HealthCare Intelligence Markets unravels its new study titled Obesity Intervention Devices Market. Effective exploratory techniques such as qualitative and quantitative analysis have been used to discover accurate data. For an effective business outlook, it studies North America, Latin America, Asia-Pacific, Japan, and India by considering different aspects such as type, size, as well as applications. SWOT and Porter’s five analysis have been used to analyse cost, prices, revenue, and end-users.…
Intragastric Balloon Market In depth research analysis| Key Player: Allurion Tec …
The Intragastric Balloons Market size is expected to exceed USD 270 million by 2024; as per a new research report by Global Market Insights.
Strong obesity and associated disease prevalence will drive the industry, increasing healthcare expenditure and improved awareness regarding early diagnosis of obesity will fuel business growth. Growing acceptance of minimally invasive techniques should also fuel intragastric balloons market growth. Positive regulatory approval rates of these systems have evolved…
Intragastric Balloon Market| Key Player: Allurion Technologies, Silimed, Distric …
The Intragastric Balloons Market size is expected to exceed USD 270 million by 2024; as per a new research report by Global Market Insights.
Strong obesity and associated disease prevalence will drive the industry, increasing healthcare expenditure and improved awareness regarding early diagnosis of obesity will fuel business growth. Growing acceptance of minimally invasive techniques should also fuel intragastric balloons market growth. Positive regulatory approval rates of these systems have evolved…
Intragastric Balloon Market| Key Player: Allurion Technologies, Silimed, Distric …
The Intragastric Balloons Market size is expected to exceed USD 270 million by 2024; as per a new research report by Global Market Insights.
Strong obesity and associated disease prevalence will drive the industry, increasing healthcare expenditure and improved awareness regarding early diagnosis of obesity will fuel business growth. Growing acceptance of minimally invasive techniques should also fuel intragastric balloons market growth. Positive regulatory approval rates of these systems have evolved…
